{"title":"抗精神病新药再普乐用于临床","authors":["王仁倜"],"dates":[{"year":1999,"month":4,"day":20}],"parts":[{"type":"paragraph","text":"抗精神病新药再普乐用于临床"},{"type":"paragraph","text":"本报讯记者王仁倜报道：抗精神病新药再普乐，经国家药品监督管理局批准，日前在我国正式用于临床。再普乐通过调节脑内多种神经递质，改变脑中多种神经通路的功能，全面改善精神分裂症症状，包括阳性、阴性、情感和认知障碍。"}],"comments":[],"comment_pivots":[],"description":"","page_start":5,"page_end":5}